Day Trading News
News on Day Trading continually updated from thousands of sources around the net.
7 hrs ago | SchaeffersResearch.com
Global concerns were top of mind throughout the week. Tensions continued to flare in Ukraine, and all eyes turned toward Crimea, which will vote Sunday on whether to declare itself part of Russia.
Trending on the Topix Network
11 hrs ago | SchaeffersResearch.com
After shedding nearly 3% yesterday in the wake of a patent defeat , Pfizer Inc. is on the mend today, up 0.7% at last check to linger near $31.33.
15 hrs ago | Hispanic Business
The major averages have spent the day bouncing back and forth across the unchanged line.
It's a trend witnessed in today's session, where calls are outpacing puts by a more than 2-to-1 margin.
Russia's attempted annexation of the Ukraine, China's internal economic woes, the less than auspicious enrollment numbers in Obama's health care initiative are just a few of the difficulties that the stock market has had to overcome this week.
Nevertheless, options speculators are wagering on a recovery for the stock, with calls trading at a 49% mark-up to NOK's average intraday volume.
While analysts continue to praise Facebook Inc for its technical advances, investors and option traders have been upping the bearish ante on the stock of late.
However, nearly three-quarters of the day's put volume centered on two strikes, as one option trader readjusted her bearish bet, calling for more downside for the struggling stock over the next several months.
After moving higher in early trading, the Dow Jones Industrial Average has reversed course, despite weekly jobless claims unexpectedly falling and February retail sales beating estimates.
It was the worst day for the market in six weeks and the fourth loss in a row for the Dow.
On Thursday's session, BPCL closed at Rs 443.15 per share, a jump of 7.25% from the previous close, its all time high.
The Dow Jones Industrial Average is pointed higher, as traders brush off weak economic data out of China and turn to today's round of domestic data points.
Against this backdrop, Macquarie lifted its price target on S to $9.25 from $8.65, though most analysts remain in the bears' corner.
Though the equity is seemingly undeserving of bullish sentiment -- sporting a one-month loss of nearly 5% to trade at $21.61 -- the recent surge of optimism among analysts is just more of the same.
The stock has edged 0.2% higher today to $75.21, but this rally may be short-lived, as the shares are encountering some formidable technical resistance.
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.